| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.43 | 0.1 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |